Is risankizumab better than secukinumab in the treatment of plaque psoriasis?

Plaque psoriasis is a common inflammatory disease that causes raised, flaky plaques or patches on the skin. An abnormal immune system can be an important cause of psoriasis. Risankizumab and secukinumab are biologic drugs injected under patient’s skin to treat different parts system. Both approved in U. S. E. moderate‐to‐severe plaque